# Microvascular Obstruction Diagnosis Using the CoFI™ System Assessment - II

Study · id `cardio:ct-nct06909578` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06909578](<https://clinicaltrials.gov/study/NCT06909578>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06909578

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 200 participants.

## Technical summary

Registry record NCT06909578. Allocation not applicable; no masking; primary purpose diagnostic. Start 2025-09-01 (anticipated); primary completion 2026-12-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase: Not applicable
- Enrolled: 200 participants (planned count; ClinicalTrials.gov record NCT06909578, source copy `cardio:ctgov-nct06909578-2025-07-10`, retrieved 2026-10-26)
- Planned start: 2025-09-01 (anticipated) (ClinicalTrials.gov record NCT06909578, source copy `cardio:ctgov-nct06909578-2025-07-10`, retrieved 2026-10-26)
- Primary completion: 2026-12-01 (anticipated) (ClinicalTrials.gov record NCT06909578, source copy `cardio:ctgov-nct06909578-2025-07-10`, retrieved 2026-10-26)
- Completion: 2026-12-01 (anticipated) (ClinicalTrials.gov record NCT06909578, source copy `cardio:ctgov-nct06909578-2025-07-10`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06909578-2025-07-10`, retrieved 2026-10-26)

## The registry's words

- Brief title: Microvascular Obstruction Diagnosis Using the CoFI™ System Assessment - II
- Acronym: MOCA II
- Condition: Microvascular Obstruction (MVO)
- Condition: STEMI - ST Elevation Myocardial Infarction
- Intervention (Device): CorFlow Controlled Flow Infusion System - CoFI™
- Lead sponsor: CorFlow Therapeutics AG
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: ST-elevation heart attack (STEMI) (`cardio:stemi`)

## Provenance

Content hash: 185e577f369d87c31fca0391191cad8346b2fe9f9b0dbfa0cc0d0b458deb868a
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
